Personalised medicine is a fast-moving field that sees treatments and medicines tailored to a patient’s genes, as well as his or her environment and lifestyle, writes...
Brussels-based multi-stakeholder organization the European Alliance for Personalised Medicine (EAPM) was delighted to note that four MEPs with who it has worked closely in recent years...
This week, the European Medicines Agency (EMA) launched its PRIME scheme. This stands for PRIority MEdicines and is intended to “strengthen support to medicines that target...
Less than a month ago, (17 February) the European parliament’s ENVI committee took a step towards changing the way medicines are approved at European level. This...
Warsaw, Poland: The European Alliance for Personalised Medicine’s (EAPM) latest SMART Outreach meeting in Warsaw, Poland (1-2 March) found consensus with the Polish Alliance for Personalised...
In the news at the moment is Apple’s battle with a demand from the US Justice Department that the company builds a “back door” into one of...
The European Alliance for Personalised Medicine’s (EAPM) latest SMART Outreach meetings are taking shape to set up an Alliance presence nationally, writes EAPM Executive Director Denis Horgan. The...